CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-10-10
著者
-
SANDANARAJ Edwin
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
-
LAL Suman
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
-
CHOWBAY Balram
Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer
-
Lee Edmund
Department Of Pharmacology Yong Loo Lin School Of Medicine National University Of Singapore
-
Lal Suman
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
-
Wong Zee
Department Of Medical Oncology National Cancer Center
-
Ang Peter
Department Of Medical Oncology National Cancer Center
-
Wong Nan
Department Of Medical Oncology National Cancer Center
-
Chowbay Balram
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
-
Sandanaraj Edwin
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
-
Chowbay Balram
Laboratory Of Clinical Pharmacology Division Of Medical Sciences Humphrey Oei Institute Of Cancer Re
-
LEE Edmund
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore
関連論文
- VKORC1 Diplotype-Derived Dosing Model to Explain Variability in Warfarin Dose Requirements in Asian Patients
- Genetic Variations of the SLC22A4 Gene in Chinese and Indian Populations of Singapore
- Genetic Variations of the SLCO1B1 Gene in the Chinese, Malay and Indian Populations of Singapore
- Genetic Variations of the ABCC2 Gene in the Chinese, Malay, and Indian Populations of Singapore
- Genetic Variations in the MCT1 (SLC16A1) Gene in the Chinese Population of Singapore
- CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients
- Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
- Role of UGT1A1^*6, UGT1A1^*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
- Identification of Functional Promoter Haplotypes of Human Concentrative Nucleoside Transporter 2, hCNT2 (SLC28A2)
- Genetic Variations of the SLC22A5 Gene in the Chinese and Indian Populations of Singapore
- Pharmacogenetics of CYP1A2, Novel Polymorphisms and Haplotypes in Three Distinct Asian Populations
- Effects of bromocriptine on hepatic cytochrome P-450 monooxygenase system.